Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Birth control pills and antiandrogens are the most effective medicines for excessive body hair in women, but combining them with other treatments and psychological support is best.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

People with severe acne tend to have higher levels of betatrophin.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.